Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.710
+0.1602.88%
Volume:91.38M
Turnover:522.19M
Market Cap:106.68B
PE:37.66
High:5.800
Open:5.485
Low:5.485
Close:5.550
52wk High:8.335
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:1.54
T/O Rate:0.49%
Dividend:0.12
Dividend Rate:2.10%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.80
PE(LYR):37.66
PS:2.71

Loading ...

Sino Biopharmaceutical Stock Rises 8.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 21

Hang Seng Index Rallies into the Close, up More Than 1%, Testing the 25,000 Level

Tiger Newspress
·
Sep 21

Hong Kong Stock Movers | SBP Group Surges Over 6% as Management Reaffirms Annual Revenue Target, with Newly Approved Innovative Drugs Set to Drive Sustained Sales Growth

Stock News
·
Sep 21

Movement Alert|SBP GROUP Rises 3.11% in Regular Trading, Management Reaffirms Double-Digit Revenue Growth Guidance with Buy Rating from Daiwa

Market Focus
·
Sep 21

Daiwa Reaffirms Buy Rating on SBP Group After Management Reiterates Double-Digit Revenue Growth Target for the Year

Deep News
·
Sep 20

Daiwa Highlights SBP Group's Reaffirmed Double-Digit Revenue Growth Target for This Year, Retains "Buy" Rating

Stock News
·
Sep 18

Movement Alert|SBP GROUP Rises 3.18% in Regular Trading, Dual NDA Acceptances and CT Tianqing Stake Increase Completion Fuel Gains

Market Focus
·
Sep 18

Hong Kong Stocks in Focus: SBP Group Jumps Nearly 3% on Double New Drug Approval Submissions

Stock News
·
Sep 16

Sino Biopharmaceutical Says China's CDE Accepts NDA for Tqh2722 Injection

Reuters
·
Sep 16

Hong Kong Market Open: Hang Seng Index Rises 0.50% as Optics Stocks Rally, CATL Slides Over 2%

Stock News
·
Sep 16

Chinese Regulator Accepts NDA for Sino Biopharm's Breast Cancer Drug

MT Newswires Live
·
Sep 16

Sino Biopharm (SBP Group) Receives CDE Acceptance of NDA for IL-4Rα Monoclonal Antibody TQH2722 Targeting Moderate-to-Severe Atopic Dermatitis

Bulletin Express
·
Sep 16

China Biopharmaceuticals Advances Novel HER2-Targeting Bispecific ADC Toward Market Approval

Stock News
·
Sep 16

Sino Biopharmaceutical - China Cde Accepts New Drug Application for Tqb2102 Injection

THOMSON REUTERS
·
Sep 16

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Dow Jones
·
Sep 15

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Sino Biopharmaceutical Climbs on Plan to Raise Stake in Core Unit

Reuters
·
Sep 14

Goldman Sachs Lifts SBP Group Target Price to HK$9.07, Reaffirms Buy Rating

Stock News
·
Sep 14

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Sep 14